Immunicum AB (publ) Presents Preclinical Data on Ilixadencel in Combination with Cancer Therapies and Immunotherapies at the 2020 Virtual ESMO Congress

    NEXT STORY
    New Data from Ciforadenant Phase 1b/2 Clinical Study Presented at ESMO Virtual Congress 2020
    PREV STORY
    Tiziana Life Sciences plc to Conduct a Clinical Study with Nasally Administered Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, for Treatment of COVID-19 Patients in Brazil
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Global Pelvic Inflammatory Disease Therapeutics Market – Growth, Trends, and Forecast (2020 to 2025)

    author_avatar
    NASDAQ Market News

    Bavarian Nordic to Host Third Quarter 2018 Results Conference Call

    COPENHAGEN, Denmark - November 2, 2018 - Bavarian Nordic A/S (OMX:  BAVA, OTC: BVNRY) ...

    author_avatar
    NASDAQ Market News

    Retrophin Names Eric Dube, Ph.D. President and Chief Executive Officer

    Dr. Dube brings proven track record of global leadership built upon significant commercial and ...

    author_avatar
    NASDAQ Market News